Page last updated: 2024-11-12

astacin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

astacin: a zinc-endopeptidase from the crayfish Astacus astacus & Hydra vulgaris; releases nitroaniline from succinyl-alanyl-alanyl-alanyl-4-nitroanilide (Suc-Ala-Ala-Ala-pNA); acts on peptides containing 5 or more amino acids, preferably with ALA in P1' and Pro in P2' [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

astacene : A carotenone that consists of beta,beta-carotene bearing four oxo substituents at positions 2, 2', 4 and 4'. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID20054842
CHEBI ID35327
SCHEMBL ID76100
MeSH IDM0193723

Synonyms (14)

Synonym
beta,beta-carotene-3,3',4,4'-tetrone
1jrm9z96g0 ,
514-76-1
unii-1jrm9z96g0
astacin
CHEBI:35327
astacene
SCHEMBL76100
all-trans-.beta.-carotene-3,3',4,4'-tetrone
astacin [mi]
.beta.,.beta.-carotene-3,3',4,4'-tetrone
RASZIXQTZOARSV-QISQUURKSA-N
Q4810499
3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3,4-dioxocyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-ene-1,2-dione

Research Excerpts

Overview

The astacins are a family of metallopeptidases that share a central ∼200-residue catalytic domain (CD), which is found in >1000 species across holozoans and, sporadically, bacteria. Astacins are a subfamily of the metzincin superfamily of meetalloproteinases.

ExcerptReferenceRelevance
"The astacins are a family of metallopeptidases that share a central ∼200-residue catalytic domain (CD), which is found in >1000 species across holozoans and, sporadically, bacteria."( Zymogenic latency in an ∼250-million-year-old astacin metallopeptidase.
Becker-Pauly, C; Gomis-Rüth, FX; Guevara, T; Rodríguez-Banqueri, A; Stöcker, W, 2022
)
1.46
"The astacins are a subfamily of the metzincin superfamily of metalloproteinases. "( Meprins, membrane-bound and secreted astacin metalloproteinases.
Bond, JS; Sterchi, EE; Stöcker, W, 2008
)
1.18
"Astacins are a large family of zinc metalloproteases found in bacteria and animals. "( Characterization of the astacin family of metalloproteases in C. elegans.
Baillie, DL; Hutter, H; Johnsen, R; Moerman, DG; Möhrlen, F; Pan, J; Park, JO; Schupp, MO; Zapf, R, 2010
)
2.11
"The astacins are a family of multi-domain metallopeptidases with manifold functions in metabolism. "( Functional and structural insights into astacin metallopeptidases.
Gomis-Rüth, FX; Stöcker, W; Trillo-Muyo, S, 2012
)
1.2

Effects

The astacin structure has been solved by multiple isomorphous replacement using six heavy-atom derivatives. Many astacins have been shown to play critical roles in embryonic hatching, dorsal/ventral patterning, and early developmental decisions.

ExcerptReferenceRelevance
"The astacin structure has been solved by multiple isomorphous replacement using six heavy-atom derivatives, and refined to a crystallographic R-value of 0.158 applying stringent constraints."( Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin.
Bode, W; Gomis-Rüth, FX; Huber, R; Stöcker, W; Zwilling, R, 1993
)
1.03
"Many astacins have been shown to play critical roles in embryonic hatching, dorsal/ventral patterning, and early developmental decisions."( The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1.
Arnold, WV; Fertala, A; Hojima, Y; Li, SW; Prockop, DJ; Sieron, AL, 1996
)
0.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carotenone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (111)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.80)18.7374
1990's46 (41.44)18.2507
2000's34 (30.63)29.6817
2010's24 (21.62)24.3611
2020's5 (4.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.53 (24.57)
Research Supply Index4.77 (2.92)
Research Growth Index6.11 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (6.84%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other109 (93.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]